Discover 1,294 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Surprise AZ, Peoria AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06958328
Phase 3, Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Surprise AZ, Peoria AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase 2, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Surprise AZ, Peoria AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
New
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
for
Hypercholesterolaemia
Location: Sun City West AZ, Pomona CA, Mesquite TX, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07619118
Phase 3, Recruiting
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
for
Renal Insufficiency, Chronic
Location: Surprise AZ, Concord CA, Stephenville TX, Fort Worth TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07624305
Phase 3, Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
for
Obesity, Overweight, Chronic Weight Management,
Location: Sun City West AZ, Phoenix AZ, Chandler AZ, Tucson AZ,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07654374
Phase 3, Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: Sun City West AZ, Phoenix AZ, Chandler AZ, Tucson AZ,
Sponsor: Ardelyx
Sex: All
Age: 18 - 70+
Code: NCT07382167
Phase 3, Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Litchfield Park AZ, Scottsdale AZ, Chandler AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07196722
Phase 2, Phase 3, Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
for
Colitis, Ulcerative
Location: Litchfield Park AZ, Scottsdale AZ, Chandler AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 12+
Code: NCT07196748
Phase 3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for
High Risk Cardiovascular Disease, Hypertension,
Location: Sun City West AZ, Sun City AZ, Phoenix AZ, Tempe AZ,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07181109
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Surprise AZ, Tucson AZ, Fullerton CA, Los Alamitos CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
CCM OPEN HF Registry
for
Heart Failure
Location: Surprise AZ, Mesa AZ, El Paso TX, Oklahoma City OK,
Sponsor: Impulse Dynamics
Sex: All
Age: 18+
Code: NCT07112924
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration